Showing results (201-210 of 9,098) with videos related to
Sort By:
Pageof 910
Cancer Medicine|August 10, 2017
Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian settingHla-Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, et al.Cancer Medicine|August 13, 2017
INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trialYehuda Z Patt, Waheed Murad, Mohammed H Fekrazad, et al.Cancer Medicine|September 24, 2017
Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumorsYuki Yamamoto, Masaki Nagasato, Yosei Rin, et al.Cancer Medicine|September 24, 2017
Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic miceTingting Fan, Zhuona Rong, Jianyi Dong, et al.Cancer Medicine|August 5, 2017
Shorter telomere length increases age-related tumor risks in von Hippel-Lindau disease patientsJiang-Yi Wang, Shuang-He Peng, Xiang-Hui Ning, et al.Cancer Medicine|September 16, 2017
Validation of the American Joint Commission on Cancer (8th edition) changes for patients with stage III gastric cancer: survival analysis of a large series from a Specialized Eastern CenterJun Lu, Chao-Hui Zheng, Long-Long Cao, et al.Cancer Medicine|September 1, 2017
Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysisYan Chen, Xiang Yu, Yongcan Xu, et al.Cancer Medicine|July 8, 2016
Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinomaE Christina M Wennerström, Rosa A Risques, Donna Prunkard, et al.Cancer Medicine|July 27, 2017
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcomaTakaaki Nakai, Yoshinori Imura, Hironari Tamiya, et al.Cancer Medicine|July 19, 2017
High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancerHailing Hou, Puchun Er, Jingjing Cheng, et al.Pageof 910